AXA Equitable doesn't anticipate any fresh need for capital injections this year or in 2010, its chief executive said Wednesday.

AXA Equitable CEO Christopher Condron told an analyst meeting that the U.S. arm of French insurance giant AXA SA's(AXA) capital ratios are stabilizing, after the substantial drop in the value of the company's holding in U.S. investment manager AllianceBernstein required a capital injection from its parent to cover a $3 billion balance-sheet hole.

Condron said AXA Equitable has re-allocated some AllianceBernstein stock throughout the AXA group and instituted a protection program to cover the market equity decline. He added that AllianceBernstein's share price has stabilized.

Company Web site: www.axa.com

-By A.H. Mooradian, Dow Jones Newswires; +33 1 4017 1740, art.mooradian@dowjones.com